{
    "title": "113_s2722",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Protecting Our Infants Act of \n2014''.\n\nSEC. 2. EVIDENCE-INFORMED RECOMMENDATIONS WITH RESPECT TO MATERNAL \n              ADDICTION AND NEONATAL ABSTINENCE SYNDROME.\n\n    (a) In General.--The Secretary of Health and Human Services \n(referred to in this section as the ``Secretary'') shall coordinate and \nfacilitate the--\n            (1) identification and compilation of evidence-informed \n        recommendations for physicians, nurses, and hospital facilities \n        with respect to neonatal abstinence syndrome; and\n            (2) identification of any gaps, as appropriate, in such \n        evidence-informed recommendations that may require additional \n        research or analysis with respect to--\n                    (A) screening and intervention for maternal \n                substance abuse, including the misuse or abuse of \n                prescription drugs in women of childbearing age and \n                pregnant women;\n                    (B) treatment for pregnant and postpartum women \n                with a substance use disorder, including the misuse or \n                abuse of prescription drugs;\n                    (C) screening of infants for neonatal abstinence \n                syndrome and for the risk of developing neonatal \n                abstinence syndrome;\n                    (D) treatment for infants with neonatal abstinence \n                syndrome, including evidence-informed recommendations \n                surrounding evaluation and treatment with \n                pharmacological and non-pharmacological interventions; \n                and\n                    (E) ongoing treatment, services, and supports for \n                postpartum women with a substance use disorder, \n                including misuse or abuse of prescription drugs, and \n                infants and children with neonatal abstinence syndrome.\n    (b) Input.--In carrying out subsection (a), the Secretary shall \nconsider input from stakeholders, such as health professionals, public \nhealth officials, and law enforcement.\n    (c) Dissemination of Information.--The Secretary shall disseminate \nto appropriate stakeholders in States and local communities the \nevidence-informed recommendations identified under subsection (a).\n    (d) Addressing Research Needs for Maternal Addiction and Neonatal \nAbstinence Syndrome.--The Secretary shall conduct a study to evaluate--\n            (1) factors related to the increased prevalence of maternal \n        opiate misuse and abuse;\n            (2) factors related to maternal misuse and abuse of \n        opiates, including--\n                    (A) barriers to identifying and treating maternal \n                misuse and abuse of opiates; and\n                    (B) the most effective prevention and treatment \n                strategies for pregnant women and other women of \n                childbearing age who are at risk for or dependent on \n                opiates; and\n            (3) factors related to neonatal abstinence syndrome, \n        including--\n                    (A) epidemiological studies concerning neonatal \n                abstinence syndrome;\n                    (B) the most effective methods to diagnose and \n                treat neonatal abstinence syndrome; and\n                    (C) the long-term effects of neonatal abstinence \n                syndrome and the need for a longer-term study on \n                infants and children at risk for developing neonatal \n                abstinence syndrome or diagnosed with neonatal \n                abstinence syndrome.\n    (e) Report.--Not later than 1 year after the date of enactment of \nthis Act, the Secretary shall provide to the Committee on Health, \nEducation, Labor, and Pensions of the Senate and the Committee on \nEnergy and Commerce of the House of Representatives the findings from \nthe study under subsection (d) and a report that identifies the gaps in \nevidence-informed recommendations that require additional research or \nanalysis, and priority areas for additional research.\n\nSEC. 3. IMPROVING DATA ON NEONATAL ABSTINENCE SYNDROME.\n\n    The Secretary of Health and Human Services, acting through the \nDirector of the Centers for Disease Control and Prevention, shall \nprovide technical assistance to States to improve the availability and \nquality of data collection and surveillance activities regarding \nneonatal abstinence syndrome, including--\n            (1) incidence and prevalence of neonatal abstinence \n        syndrome;\n            (2) the identification of causes for neonatal abstinence \n        syndrome, including new and emerging trends; and\n            (3) the identification of demographics and other relevant \n        information associated with neonatal abstinence syndrome.\n\nSEC. 4. PAIN MANAGEMENT ALTERNATIVES.\n\n    It is the sense of Congress that the Director of the National \nInstitutes of Health should continue research with respect to pain \nmanagement, including for women of childbearing age.\n\nSEC. 5. GAO STUDY.\n\n    Not later than 1 year after the date of enactment of this Act, the \nComptroller General of the United States shall conduct a study \nevaluating--\n            (1) the availability and effectiveness of federally \n        facilitated substance abuse treatment programs for pregnant \n        women and their children;\n            (2) the availability and effectiveness of Federal programs \n        that encourage State adoption and implementation of programs to \n        ensure--\n                    (A) the safety and health of mothers who have a \n                substance use disorder; and\n                    (B) the safety and health of children with neonatal \n                abstinence syndrome;\n            (3) the effectiveness of Federal data systems and \n        surveillance programs used to monitor or track drug utilization \n        and resulting trends, including whether information on neonatal \n        abstinence syndrome is incorporated into such data systems; and\n            (4) the identification of the use of all discretionary \n        funds to address maternal substance abuse, including the misuse \n        and abuse of prescription drugs."
}